Jefferies Financial Group’s Cidara Therapeutics CDTX Stock Holding History

Jefferies Financial Group’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-766,520	Closed	-$169M	–	1789
2025 Q4	$169M	Buy	766,520 +401,520	+110%	+$64.9M	0.87%	15
2025 Q3	$35M	Sell	365,000 -85,000	-19%	-$5.42M	0.17%	91
2025 Q2	$21.9M	Buy	+450,000	New	+$10.8M	0.18%	97

Jefferies Financial Group's CDTX Position: Q1 2026 in Review

Jefferies Financial Group sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 766,520 shares — an estimated $169M sold.

Jefferies Financial Group first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $169M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Jefferies Financial Group reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 766,520 Cidara Therapeutics shares in Q1 2026, an estimated $169M.
Jefferies Financial Group first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Jefferies Financial Group's Cidara Therapeutics position peaked at $169M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.